Glaxosmithkline Pharmaceuticals has informed that the meeting of the Board of Directors of the Company is scheduled on 10/02/2025 to consider and approve Un Audited financial results for quarter and nine months ended 31st December 2024.
The above information is a part of company’s filings submitted to BSE.